SCM
Sio Capital Management’s Avalo Therapeutics AVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $360K | Buy |
72,173
+715
| +1% | +$3.57K | 0.14% | 43 |
|
|
2025
Q1 | $572K | Hold |
71,458
| – | – | 0.17% | 44 |
|
|
2024
Q4 | $531K | Hold |
71,458
| – | – | 0.15% | 42 |
|
|
2024
Q3 | $679K | Hold |
71,458
| – | – | 0.27% | 28 |
|
|
2024
Q2 | $891K | Buy |
71,458
+61,307
| +604% | +$764K | 0.24% | 37 |
|
|
2024
Q1 | $221K | Buy |
+10,151
| New | +$221K | 0.07% | 44 |
|
|
2021
Q2 | – | Sell |
-552,241
| Closed | -$1.67M | – | 74 |
|
|
2021
Q1 | $1.67M | Sell |
552,241
-375,505
| -40% | -$1.13M | 0.34% | 65 |
|
|
2020
Q4 | $2.45M | Sell |
927,746
-103,030
| -10% | -$272K | 0.5% | 60 |
|
|
2020
Q3 | $2.35M | Buy |
1,030,776
+30,776
| +3% | +$70K | 0.46% | 50 |
|
|
2020
Q2 | $2.6M | Buy |
+1,000,000
| New | +$2.6M | 0.76% | 43 |
|